Insider · CIK 0000929985
MCENANY PATRICK J
directorother
Files at CPRX (CATALYST PHARMACEUTICALS, INC.). First filing Nov 13, 2024, latest Nov 21, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $18M sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 40Moderate | sell 4 | CPRX CATALYST PHARMACEUTICALS, INC. | $3.6M | 170,845 | -4% | - | |
| 40Moderate | sell 4 | CPRX CATALYST PHARMACEUTICALS, INC. | $3.1M | 137,155 | -3% | - | |
| 38Weak | sell 2 | CPRX CATALYST PHARMACEUTICALS, INC. | $12M | 492,000 | -10% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 9, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | MOption exercise Common Stock, par value $0.001 per share | +3,533 | - | - | 4,481,702 | Dec 11, 2024 |
| Dec 9, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitsderivative | -3,533 | $0.00 | $0 | 1,838,130 | Dec 11, 2024 |
| Nov 21, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | AGrant or award Options to purchase common stockderivative | +43,591 | $0.00 | $0 | 1,836,336 | Nov 25, 2024 |
| Nov 21, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | AGrant or award Restricted Stock Unitsderivative | +5,327 | $0.00 | $0 | 1,841,663 | Nov 25, 2024 |
| Nov 19, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | MOption exercise Common stock, par value $0.001 per share | +98,345 | $3.54 | $348k | 4,576,514 | Nov 21, 2024 |
| Nov 19, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | SOpen-market sale Common stock, par value $0.001 per share | -98,345 | $21.19 | $2.1M | 4,478,169 | Nov 21, 2024 |
| Nov 20, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | MOption exercise Common stock, par value $0.001 per share | +72,500 | $3.54 | $257k | 4,550,669 | Nov 21, 2024 |
| Nov 20, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | SOpen-market sale Common stock, par value $0.001 per share | -72,500 | $21.29 | $1.5M | 4,478,169 | Nov 21, 2024 |
| Nov 19, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | MOption exercise Options to purchase common stockderivative | -98,345 | $0.00 | $0 | 1,865,245 | Nov 21, 2024 |
| Nov 20, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | MOption exercise Options to purchase common stockderivative | -72,500 | $0.00 | $0 | 1,792,745 | Nov 21, 2024 |
| Nov 13, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | MOption exercise Common stock, par value $0.001 per share | +92,500 | $3.54 | $327k | 4,570,669 | Nov 15, 2024 |
| Nov 13, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | SOpen-market sale Common stock, par value $0.001 per share | -92,500 | $22.98 | $2.1M | 4,478,169 | Nov 15, 2024 |
| Nov 14, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | MOption exercise Common stock, par value $0.001 per share | +44,655 | $3.54 | $158k | 4,522,824 | Nov 15, 2024 |
| Nov 14, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | SOpen-market sale Common stock, par value $0.001 per share | -44,655 | $21.75 | $971k | 4,478,169 | Nov 15, 2024 |
| Nov 13, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | MOption exercise Options to purchase common stockderivative | -92,500 | $0.00 | $0 | 2,008,245 | Nov 15, 2024 |
| Nov 14, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | MOption exercise Options to purchase common stockderivative | -44,655 | $0.00 | $0 | 1,963,590 | Nov 15, 2024 |
| Nov 11, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | MOption exercise Common stock, par value $0.001 per share | +230,000 | $4.01 | $922k | 4,708,169 | Nov 13, 2024 |
| Nov 11, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | SOpen-market sale Common stock, par value $0.001 per share | -230,000 | $23.55 | $5.4M | 4,478,169 | Nov 13, 2024 |
| Nov 12, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | MOption exercise Common stock, par value $0.001 per share | +70,000 | $4.01 | $281k | 4,548,169 | Nov 13, 2024 |
| Nov 12, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | SOpen-market sale Common stock, par value $0.001 per share | -70,000 | $23.42 | $1.6M | 4,478,169 | Nov 13, 2024 |
| Nov 12, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | MOption exercise Common stock, par value $0.001 per share | +192,000 | $3.54 | $680k | 4,670,169 | Nov 13, 2024 |
| Nov 12, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | SOpen-market sale Common stock, par value $0.001 per share | -192,000 | $23.20 | $4.5M | 4,478,169 | Nov 13, 2024 |
| Nov 11, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | MOption exercise Options to purchase common stockderivative | -230,000 | $0.00 | $0 | 2,362,745 | Nov 13, 2024 |
| Nov 12, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | MOption exercise Options to purchase common stockderivative | -70,000 | $0.00 | $0 | 2,292,745 | Nov 13, 2024 |
| Nov 12, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | MOption exercise Options to purchase common stockderivative | -192,000 | $0.00 | $0 | 2,100,745 | Nov 13, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.